Progressive encephalopathy with leukodystrophy due to DECR deficiency

Get in touch with RARE Concierge.

Contact RARE Concierge

Progressive encephalopathy with leukodystrophy due to DECR deficiency

Synonyms: 2,4-dienoyl-CoA reductase deficiency | DECR deficiency with hyperlysinemia

Progressive encephalopathy with leukodystrophy due to DECR deficiency is a rare mitochondrial disease which presents with neonatal hypotonia central nervous system abnormalities (ventriculomegaly corpus callosum hypoplasia cerebellar atrophy) acquired microcephaly failure to thrive developmental delay and intermittent lactic acidosis provoked by catabolic stress (e.g. infection). Hyperlysinemia and elevated C10:2 carnitine can be detected in plasma. Later on epilepsy cerebellar ataxia renal tubular acidosis severe encephalopathy dystonia spastic quadriplegia and other complications may develop.

Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview.

Reference: Access aggregated data from Orphanet at Orphadata.

Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http://www.orphadata.org. Data version April 2024

Newly diagnosed with
Progressive encephalopathy with leukodystrophy due to DECR deficiency?

Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.

Get Concierge Help

Advocacy Organizations

Aicardi-Goutieres Syndrome Advocacy Association

AGSAA is a global coalition of deeply dedicated parent advocates working alongside clinicians, researchers, and scientists. We are united in our desire to improve the lives of individuals and families living with Aicardi-Goutières Syndrome and those yet to be diagnosed. Everything we do reflects a sense of urgency to rescue patient potential and preserve quality of life through accelerating research and providing timely emotional and educational support alongside evolving clinical care recommendations to affected families.

Mississippi Metabolics Foundation

Our mission at Mississippi Metabolics Foundation (MMF) is to advocate, educate, and support families in MS affected by genetic metabolic disorders/inborn errors of metabolism (IEM's). MMF promotes initiatives and further advancements in legislation, education, research, clinical trials, studies, therapies, targeted treatments, and eventual cures for IEM’s and all rare diseases.

Clinical Trials

For a list of clinical trials in this disease area, please click here.